MMED posts 17% Q1 FY27 net sales growth, lifts guidance
MMED reported 17% Q1 FY27 net sales growth and raised full-year organic revenue growth guidance to 10.5%. It also cited an adjusted EBITDA margin of 16%.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.